PFS | Â | |||
---|---|---|---|---|
Characteristic | Univariable analysis | Multivariable analysis | ||
HR (95%CI) | P-value | HR (95%CI) | P-value | |
Age(< / ≥ 65 years) | 0.561(0.295–1.064) | 0.077 |  |  |
Gender(Male/Female) | 1.192(0.670–2.121) | 0.551 |  |  |
Ecog(< 2/ ≥ 2) | 1.005(0.397–2.546) | 0.991 |  |  |
Tumor site(Multi-sides/Right colon /Left colon/Rectum) | 0..941(0.692–1.281) | 0.700 |  |  |
Histologic grade(Low grade/High grade) | 1.350(0.718–2.537) | 0.351 |  |  |
Number of metastatic sites(Single/Multiple) | 1.445(0.814–2.564) | 0.209 |  |  |
MMR Status(dMMR/pMMR) | 4.070(0.553–29.943) | 0.168 |  |  |
Primary tumor surgery(No/Yes) | 0.438(0.243–0.790) | 0.006* | 0.523(0.280–0.974) | 0.041* |
Intestinal obstruction(No/Yes) | 1.657(0.739–3.716) | 0.221 |  |  |
Liver metastases(No/Yes) | 2.058(1.132–3.742) | 0.018* | 1.677(0.890–3.157) | 0.109 |
Lung metastases(No/Yes) | 0.667(0.355–1.254) | 0.208 |  |  |
Peritoneal metastasis(No/Yes) | 1.813(0.840–3.915) | 0.130 |  |  |
Distant lymph node metastases(No/Yes) | 0.702(0.364–1.353) | 0.291 |  |  |
First-line medication(Chemo/Chemo + targeted therapy) | 0.734(0.413–1.304) | 0.291 |  |  |